Psychosocial Interventions for Mental and Substance Use Disorders: A Framework for Establishing Evidence-Based Standards (2015)
Chapter: Appendix A Data Sources and Methods
The Institute of Medicine (IOM) Committee on Developing Evidence-Based Standards for Psychosocial Interventions for Mental Disorders was tasked with developing a framework for the establishment of efficacy standards for psychosocial interventions used to treat individuals with mental disorders (inclusive of addictive disorders). The committee also explored strategies that different stakeholders might use to help establish these standards for psychosocial treatments. To respond comprehensively to its charge, the committee examined data from a variety of sources, including a review of the literature, open-session meetings and conference calls, public testimony and input, and other publicly available resources. The study was contracted over an 18-month period.
COMMITTEE EXPERTISE
The IOM formed a committee of 16 experts to conduct a study to respond to the study charge. The committee comprised members with expertise in health care policy, health care quality and performance, health systems research and operation, implementation science, intervention development and evaluation, primary care, professional education, clinical psychology and psychiatry, recovery-oriented care, and peer support services. Appendix B provides biographical information for each committee member.
LITERATURE REVIEW
Several strategies were used to identify literature relevant to the committee’s charge. A search of bibliographic databases, including PubMed, SCOPUS, and Web of Science, was conducted to obtain articles from peer-reviewed journals. Staff reviewed recent literature on psychosocial care to identify articles relevant to the committee’s charge and created an End-Note database. In addition, committee members, meeting participants, and members of the public submitted articles and reports on these topics. The committee’s database included more than 300 relevant articles and reports.
PUBLIC MEETINGS
The committee deliberated from March 2014 through December 2014 to conduct this expert assessment. During this period, the committee held five 2-day meetings, and committee members also participated in multiple conference calls. Two public meetings were held in conjunction with the committee’s May and July 2014 meetings, which allowed committee members to obtain additional information on specific aspects of the study charge (see Boxes A-1 and A-2).
The first public meeting focused on approaches to quality measurement both in and outside the mental health care field. The second public meeting focused on approaches to quality improvement both in and outside the mental health care field, and included speakers with expertise in the fields of treatment fidelity, implementation, and health technology.
Each open-session meeting included a public comment period in which the committee invited input from any interested party. All open-session meetings were held in Washington, DC. A conference call number and online public comment tool were provided to allow opportunity for input from those unable to travel to the meetings. A link to the public comment tool was made available on the National Academies’ website from January 2014 to March 2015, and all online comments were catalogued in the study’s public access file. Any information provided to the committee from outside sources or through the online comment tool is available by request through the National Academies’ Public Access Records Office. The agendas for the two open-session committee meetings are presented below.
BOX A-1
Agenda for Public Workshop on Quality Measurement
Keck Center, Room 101
The National Academies
500 Fifth Street, NW
Washington, DC
May 19, 2014
| 1:00 p.m. | Welcome and Introductions Mary Jane England, M.D., Chair |
| 1:10 p.m. | Panel Discussion: Broad Issues in Quality Measurement Sarah Hudson Scholle, Dr.P.H., M.P.H., Panel Moderator |
|
Helen Burstin, M.D., M.P.H. Senior Vice President for Performance Measures National Quality Forum |
|
|
Shari M. Ling, M.D.
Deputy Chief Medical Officer Center for Clinical Standards and Quality Centers for Medicare & Medicaid Services |
|
|
Eric C. Schneider, M.S., M.D.
Senior Scientist Distinguished Chair in Health Care Quality RAND Corporation |
|
| 2:10 p.m. | Panel Discussion: Measuring Quality in Behavioral Health Services Kermit Crawford, Ph.D., Panel Moderator |
|
Gregory J. McHugo, Ph.D.
Professor of Community and Family Medicine and of Psychiatry Associate Director, Dartmouth Psychiatric Research Center Dartmouth University |
|
|
Kimberly Hepner, Ph.D.
Senior Behavioral Scientist RAND Corporation |
|
Jodie Trafton, Ph.D.
Director, VA Program Evaluation and Resource Center, Office of Mental Health Operations, U.S. Department of Veterans Affairs Health Science Specialist, Center for Innovation to Implementation, VA Palo Alto |
|
|
Jim Chase, M.A.
President MN Community Measurement |
|
| 3:10 p.m. | Break |
| 3:30 p.m. | Panel Discussion: Measuring Quality in Other Fields Harold Pincus, M.D, Panel Moderator |
|
Matthew M. Hutter, M.D.
Assistant Professor in Surgery, Harvard Medical School Associate Visiting Surgeon, Massachusetts General Hospital |
|
|
Frank G. Opelka, M.D., FACS
President and Chief Executive, Louisiana State University Healthcare Network Associate Medical Director, American College of Surgeons Division of Advocacy and Health Policy Chair, American Medical Association–convened Physician Consortium for Performance Improvement |
|
|
Kurt C. Stange, M.D., Ph.D.
Promoting Health Across Boundaries Editor, Annals of Family Medicine Professor of Family Medicine and Community Health, Epidemiology and Biostatistics, Oncology and Sociology Case Western Reserve University |
|
|
Kevin Larsen, M.D.
Medical Director of Meaningful Use Office of the National Coordinator for Health Information Technology U.S. Department of Health and Human Services |
|
| 4:30 p.m. | Discussion |
| 5:00 p.m. | Adjourn |
BOX A-2
Agenda for Public Workshop on Quality Improvement
Keck Center, Room 101
The National Academies
500 Fifth Street, NW
Washington, DC
July 23, 2014
| 1:00 p.m. | Welcome and Introductions Mary Jane England, M.D., Chair |
| 1:10 p.m. | SAMHSA Criteria for Evaluating Evidence-Based Psychosocial Treatments |
|
Lisa C. Patton, Ph.D.
Branch Chief, Quality, Evaluation, and Performance Center for Behavioral Health Statistics and Quality Substance Abuse and Mental Health Services Administration (SAMHSA) |
|
| 1:30 p.m. | Panel Discussion: Implementation Enola Proctor, Ph.D., Panel Moderator |
|
Tracey L. Smith, Ph.D.
Mental Health Services, VA Central Office, Washington, DC |
|
|
Virna Little, Psy.D., LCSW-R, SAP
Institute for Family Health |
|
|
Abe Wandersman, Ph.D.
University of South Carolina |
|
|
Gregory Aarons, Ph.D.
University of California, San Diego |
|
| 2:40 p.m. | Panel Discussion: Treatment Fidelity Rhonda Robinson-Beale, M.D., Panel Moderator |
|
Amy Dorin, LCSW
Federation Employment and Guidance Service (FEGS) |
|
|
Sonja Schoenwald, Ph.D.
Medical University of South Carolina |
|
David Clark, D.Phil., CBE, FBA, FMedSci, HonFBPs
Improving Access to Psychological Therapies (IAPT) |
|
| 3:50 p.m. | Break |
| 4:00 p.m. | Panel Discussion: Health IT Sarah Hudson Scholle, Dr.P.H., M.P.H., Panel Moderator |
|
David Mohr, Ph.D.
Northwestern University |
|
|
Robert Gibbons, Ph.D.
University of Chicago |
|
|
Armen Arevian, M.D., Ph.D.
University of California, Los Angeles |
|
|
Grant Grissom, Ph.D.
Polaris Health Directions |
|
| 4:30 p.m. | Discussion |
| 5:00 p.m. | Adjourn |
|
July 24, 2014 |
|
| 9:00 a.m. | Health Reform and the Implications for Psychosocial Interventions |
|
Richard Frank, Ph.D.
Assistant Secretary for Planning and Evaluation (ASPE) U.S. Department of Health and Human Services |
|
| 10:00 a.m. | Adjourn |
